The cumulative false-positive rate in colorectal cancer screening: a Markov analysis

por Haug, Ulrike, Coupé, Veerle M.H.
Publicado en Eur J Gastroenterol Hepatol (2020)

Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program

por Vleugels, Jasper L. A., Greuter, Marjolein J. E., Hazewinkel, Yark, Coupé, Veerle M. H., Dekker, Evelien
Publicado en Endosc Int Open (2017)

Estimating population-based recurrence rates of colorectal cancer over time in the United States

por Kunst, Natalia, Alarid-Escudero, Fernando, Aas, Eline, Coupé, Veerle M.H., Schrag, Deborah, Kuntz, Karen M.
Publicado en Cancer Epidemiol Biomarkers Prev (2020)

Resilience of a FIT screening programme against screening fatigue: a modelling study

por Greuter, Marjolein J. E., Berkhof, Johannes, Canfell, Karen, Lew, Jie-Bin, Dekker, Evelien, Coupé, Veerle M. H.
Publicado en BMC Public Health (2016)

A Review on Cost-Effectiveness and Cost-Utility of Psychosocial Care in Cancer Patients

por Jansen, Femke, van Zwieten, Valesca, Coupé, Veerle M. H., Leemans, C. René, Verdonck-de Leeuw, Irma M.
Publicado en Asia Pac J Oncol Nurs (2016)

Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review

por Kolovos, Spyros, Bosmans, Judith E., Riper, Heleen, Chevreul, Karine, Coupé, Veerle M. H., van Tulder, Maurits W.
Publicado en Pharmacoecon Open (2017)

Costs from a healthcare and societal perspective among cancer patients after total laryngectomy: are they related to patient activation?

por Jansen, Femke, Coupé, Veerle M. H., Eerenstein, Simone E. J., Leemans, C. René, Verdonck-de Leeuw, Irma M.
Publicado en Support Care Cancer (2017)

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study

por van Lanschot, Meta C. J., Carvalho, Beatriz, Coupé, Veerle M. H., van Engeland, Manon, Dekker, Evelien, Meijer, Gerrit A.
Publicado en BMC Cancer (2017)

Cost-effectiveness of different strategies for diagnosis of uncomplicated urinary tract infections in women presenting in primary care

por Bosmans, Judith E., Coupé, Veerle M. H., Knottnerus, Bart J., Geerlings, Suzanne E., Moll van Charante, Eric P., ter Riet, Gerben
Publicado en PLoS One (2017)

Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening

por Bronzwaer, Maxime E. S., Greuter, Marjolein J. E., Bleijenberg, Arne G. C., IJspeert, Joep E. G., Dekker, Evelien, Coupé, Veerle M. H.
Publicado en BMC Cancer (2018)

Efficacy and cost-utility of the eHealth self-management application 'Oncokompas', helping partners of patients with incurable cancer to identify their unmet supportive care needs...

por Schuit, Anouk S., Holtmaat, Karen, Hooghiemstra, Nienke, Jansen, Femke, Lissenberg-Witte, Birgit I., Coupé, Veerle M. H., Verdonck-de Leeuw, Irma M.
Publicado en Trials (2020)

Cost-Effectiveness of Surveillance Scanning Strategies after Curative Treatment of Non–Small-Cell Lung Cancer

por Wolff, Henri B., Alberts, Leonie, Kastelijn, Elisabeth A., El Sharouni, Sherif Y., Schramel, Franz M. N. H., Coupé, Veerle M. H.
Publicado en Med Decis Making (2020)

The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee

por Coupé, Veerle M H, Veenhof, Cindy, van Tulder, Maurits W, Dekker, Joost, Bijlsma, Johannes W J, Van den Ende, Cornelia H M
Publicado 2007

Model-based evaluation of the cost effectiveness of 3 versus 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients

por Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Publicado en Therap Adv Gastroenterol (2020)

Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients

por Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Koopman, Miriam, Vink, Geraldine R., Punt, Cornelis J. A., Coupé, Veerle M. H.
Publicado en Therap Adv Gastroenterol (2021)

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care

por van der Meijde, Elisabeth, van den Eertwegh, Alfons J. M., Linn, Sabine C., Meijer, Gerrit A., Fijneman, Remond J. A., Coupé, Veerle M. H.
Publicado en Cancer Inform (2016)

The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis

por Greuter, Marjolein J E, Berkhof, Johannes, Fijneman, Remond J A, Demirel, Erhan, Lew, Jie-Bin, Meijer, Gerrit A, Stoker, Jaap, Coupé, Veerle M H
Publicado en Br J Radiol (2016)

Estimating adjuvant treatment effects in Stage II colon cancer: Comparing the synthesis of randomized clinical trial data to real‐world data

por Jongeneel, Gabrielle, Klausch, Thomas, van Erning, Felice N., Vink, Geraldine R., Koopman, Miriam, Punt, Cornelis J.A., Greuter, Marjolein J.E., Coupé, Veerle M.H.
Publicado en Int J Cancer (2019)

Prediction of Microscopic Metastases in Patients with Metachronous Oligo-Metastases after Curative Treatment of Non-Small Cell Lung Cancer: A Microsimulation Study

por Wolff, Henri B., Alberts, Leonie, Kastelijn, Elisabeth A., Verstegen, Naomi E., El Sharouni, Sherif Y., Schramel, Franz M. N. H., Vos, Rein, Coupé, Veerle M. H.
Publicado en Cancers (Basel) (2021)

Longitudinal effects of adjuvant chemotherapy and related neuropathy on health utility in stage II and III colon cancer patients: A prospective cohort study

por Jongeneel, Gabrielle, Greuter, Marjolein J. E., van Erning, Felice N., Twisk, Jos W. R., Koopman, Miriam, Punt, Cornelis J. A., Vink, Geraldine R., Coupé, Veerle M. H.
Publicado en Int J Cancer (2021)